F. Mayer

Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial

Jean-­Marc Ferrero, B. Weber, J.-F. Geay et al. · Annals of Oncology · 2006 · 105 citations · Full text

Medicine, Gynecology, Oncology +17

Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type

Patricia Pautier, Vincent Ribrag, Pierre Duvillard et al. · Annals of Oncology · 2007 · 100 citations

Medicine, Oncology, Surgery +17

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Markus Joerger, Joachim von Pawel, Stefanie Kraff et al. · Annals of Oncology · 2016 · 89 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction

Guillemette Laval, Hubert Rousselot, Sophie Toussaint-Martel et al. · Bulletin du Cancer · 2012 · 44 citations

Medicine, Clinical Sciences, Surgery +15

High-Dose Platinum versus Standard Dose in Advanced Ovarian Carcinoma: A Randomized Trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)

Florence Joly, Jean‐François Héron, Pierre Kerbrat et al. · Gynecologic Oncology · 2000 · 27 citations

Medicine, Gynecology, Oncology +15